2017 Round-Up: 7 of Our Favorite Posts from the Year

Last year was an exciting year for all of us here at Medtronic Diabetes, from putting the first group of people with diabetes on the MiniMed 670G system, to sponsoring a team of runners in the New York Marathon with Beyond Type 1!  It’s been my absolute pleasure to highlight some absolutely inspiring stories and showcase the role that Medtronic technology plays in some of your lives. With so much going on, we thought we’d highlight our favorite posts of 2017 in case you missed them. (There were so many great posts to choose from and these were just a few of the posts that we loved!)

A Sit Down with Our Chief Patient Officer

Our Chief Patient Officer, Louis Dias, is passionate about putting your voices at the center of everything we do.. Since joining the company, he has set a goal of creating a better culture of listening here at Medtronic. See what he has to say in his February blog post.

MiniMed™  670G System: Top Questions Answered

The MiniMed 670G system is the first of its kind, which raised a lot of questions for those interested in the new hybrid closed loop technology. Nicky was one of the first to wear the system as part the clinical trial, so she helped take some of your questions and share her experience using the system.

MiniMed 670G System: Learning to Trust

Phyllis also shared her experience with the new MiniMed 670G system with her reflection on the evolution of diabetes management. From daily beef/port insulin injections and urine tests to an automated device that manages levels, her story offers some insight into how trusting this system has allowed her to manage her diabetes.

Get Inspired: Beyond Type Run at the NYC Marathon

Living with diabetes has its highs and lows (pun intended). But, 17 inspiring runners tackled the New York City Marathon, proving that Type 1 diabetes doesn’t hold them back. They trained and pushed through head colds, low BG, and rain to cross the finish line at the country’s largest marathon.

How To: Travel With Diabetes

Whether you’re traveling for business or pleasure, diabetes shouldn’t be a distraction. Chris shared his tips on managing diabetes while traveling. Among his tips are to pack extra supplies, simple ways to treat low blood sugar, and keeping a list of emergency contacts, just in case.

How To: Manage Diabetes During Sick Days

Feeling under the weather is never fun, but combined with diabetes can require extra care.  We consulted YOU in the diabetes community for your best sick day tips.

How To: Find the Best Support Network

The personal nature of diabetes can make you feel isolated when you don’t have a support network. Everyone’s needs are different, so guest blogger Karen, offered her tips to on how to find a support network that works for you.

Did your favorite make the list? Comment below and let us know. We’ll select a random commenter to win a special Medtronic prize.

A special shout out to the LOOP Blog editorial team and guest writers for sharing your inspiring stories with us in 2017. We also got some great comments with questions and feedback from our community, so keep them coming!  Looking forward to another great year.

Editor’s Note: To ring in the new year, we’ve also updated our LOOP Blog guidelines. You can read them here.

IMPORTANT SAFETY INFORMATION

The Medtronic MiniMed 670G system requires a prescription and is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of Type 1 diabetes mellitus in persons, fourteen years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 670G System includes SmartGuard technology, which can be programmed to automatically adjust delivery of basal insulin based on Continuous Glucose Monitor sensor glucose values, and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values.

WARNING: Do not use Auto Mode for a period of time after giving a manual injection of insulin by syringe or pen. Manual injections are not accounted for in Auto Mode. Therefore, Auto Mode could deliver too much insulin. Too much insulin may cause hypoglycemia. Consult with your healthcare professional for how long you need to wait after a manual injection of insulin before you resume Auto Mode.

The Guardian Sensor (3) is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a finger stick may be required. All therapy adjustments should be based on measurements obtained using a home glucose monitor and not on values provided by the Guardian Sensor (3).

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Do not use the serter on products other than the Enlite sensor or Guardian Sensor (3). Medtronic cannot guarantee the safety or efficacy of this product if used with other products. The reservoir is contraindicated for the infusion of blood or blood products. Infusion sets are indicated for subcutaneous use only and not for intravenous (IV) infusion or the infusion of blood or blood products. Insulin pump therapy is not recommended for those who are unwilling to perform at least four blood glucose tests per day. As insulin pumps use rapid acting insulin only, BG testing is required to help identify rapid glycemic deterioration due to insulin infusion occlusion, infusion site problems, insulin stability issues, user error, or a combination of these. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional.

The safety of the 670G system has not been studied in people with impaired kidney function. Please let your healthcare professional know if you have kidney disease so you and your healthcare professional can determine if the potential benefits of using the system outweigh the risks. The safety of the 670G system has not been studied in pregnant women, people with type 2 diabetes, or in people using other anti-hyperglycemic therapies apart from insulin. Please let your healthcare professional know if any of these conditions apply to you so you and your healthcare professional can determine if the potential benefits of using the system outweigh the risks.

For complete safety information, please consult the appropriate User Guide.

Print This Post Print This Post
Tags: , , , , ,

Post A Comment

Your email address will not be published. Required fields are marked *